1. Facts and Background
Facts and Background
Nexperia B.V., formerly the Standard Products Division of Philips Semiconductors, became a fully independent Dutch company before being acquired by China’s Wingtech Technology Co., Ltd. in 2019. Between September and October 2025, the Dutch government imposed a series of restrictive measures on Nexperia, citing “national security” and “protection of critical technologies.” These included:
- Freezing of corporate assets, intellectual property, and related operations;
- Suspension of the CEO appointed by Wingtech (Mr. Zhang Xuezheng);
- Restriction of the parent company’s governance rights.
Wingtech publicly stated that these actions constitute a violation of its legitimate investment rights and announced its intent to seek remedies through legal and diplomatic channels.
2. Key Legal Issues
Key Legal Issues
- Whether the Dutch government had a valid domestic legal basis for the restrictive measures;
- Whether the measures amount to indirect expropriation or unfair and inequitable treatment (FET) under the China–Netherlands Bilateral Investment Treaty (BIT);
- What legal remedies are available to Wingtech as a foreign investor;
- Implications of this case for Chinese outbound investments in sensitive technology sectors.
3. Dutch Domestic Legal Framework
Dutch Domestic Legal Framework
The Dutch government’s actions appear to rely primarily on:
- The Investment Screening Act (Wet veiligheidstoets investeringen, fusies en overnames, 2023);
- The Enterprise Chamber Act (Ondernemingskamer) concerning corporate governance interventions;
- EU Regulation 2019/452 on the screening of foreign direct investment.
While these instruments authorize state intervention in cases involving national security or critical infrastructure, the breadth of the Nexperia measures—including restrictions on management, IP, and corporate operations—may violate the principle of proportionality and amount to administrative overreach.
4. International Investment Law Assessment
International Investment Law Assessment
1️⃣ Legal Basis
Under the China–Netherlands BIT (2001):
- Investments shall not be nationalized or expropriated except for public interest, under due process, on a non-discriminatory basis, and against prompt, adequate compensation;
- Investments are entitled to fair and equitable treatment (FET);
- Investors have rights to free transfer of returns and access to legal remedies.
2️⃣ Indirect Expropriation
Government actions that deprive an investor of effective control or economic benefits, even without formal nationalization, may constitute indirect expropriation. In the Nexperia case:
- Wingtech has lost effective control and use of its investment;
- No compensation mechanism has been provided;
- Political motivations are apparent;→ The measures satisfy the elements of indirect expropriation under international law.
3️⃣ Unfair and Inequitable Treatment (FET)
Violations of FET arise when a host state’s actions are non-transparent, discriminatory, or arbitrary, depriving investors of legitimate expectations and procedural fairness. The Dutch government’s abrupt actions without due hearing or proportional review likely constitute a breach of its FET obligations.
5. Potential Legal Remedies
Potential Legal Remedies
1️⃣ Domestic Judicial Remedies
Wingtech may seek judicial review before the Dutch Enterprise Chamber or administrative courts, alleging violations of proportionality and due process. However, remedies may be limited given the “national security” context.
2️⃣ Investor–State Arbitration (ISDS)
Under Article 9 of the BIT, Wingtech may bring a claim before ICSID or UNCITRAL arbitration, asserting:
- Indirect expropriation and breach of FET;
- Compensation for loss of share value and future profits.
Relevant precedents include:
- CME v. Czech Republic (2003)
- ADC v. Hungary (2006)
- Tecmed v. Mexico (2003)
These cases confirm that state interference under the guise of regulation can amount to expropriation.
6. Conclusions and Recommendations
Conclusions and Recommendations
| Issue | Legal Opinion |
|---|---|
| Domestic legality of Dutch measures | Formally valid but questionable under proportionality and non-discrimination principles. |
| Violation of international law | Likely constitutes indirect expropriation and FET breach. |
| Remedies available to Wingtech | Initiate ICSID/UNCITRAL arbitration and engage in diplomatic consultations. |
| Likelihood of success | Moderate to high if evidence is strong; political influence remains significant. |
| Implications for Chinese investors | Strengthen pre-acquisition due diligence, political risk insurance, and BIT-based arbitration planning. |
📘 Summary The Nexperia case superficially appears to be a matter of national security regulation, but it fundamentally reflects the expansion of economic sovereignty against the backdrop of geopolitical tensions. Legally, the measures have procedural legitimacy under domestic law, but they are highly controversial under international investment law, providing Wingtech with a solid legal basis for arbitration.